Pluromed acquired by Sanofi Biosurgery

Pluromed, a medical technology company pioneering the use of injectable plugs to improve the safety, efficacy and economics of medical interventions was acquired by Sanofi Biosurgery (NYSE: GCVRZ). >Press Release